|
Country Work in Cancer Research and Cancer Control Planning Strengthening; Kenya
|
Research Initiative
|
CDC
|
NCI, FIC, NIAID
|
Kenya has an estimated population of over 42 million. Cancer ranks third as a cause of death after infectious and cardiovascular diseases. It estimated that over 18,000 Kenyans die of cancer annually. The most common types of cancer in Kenya are cancers of the cervix, breast, esophagus, and prostate. The Ministry of Health released a National Cancer Control Strategy (2010-2015) and a National Cervical Cancer Prevention Program Strategic Plan (2012-2015). NCI looks to build upon those efforts in coordination with the many US government and non-governmental partners (NGOs) working in the country. US government agencies, including the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Disease (NIAID), the Fogarty International Center (FIC), the Centers for Disease Control (CDC), and the US Agency for International Development (USAID) have a significant presence in Kenya. Between FY2010 and FY2012, there were 121 NIH or CDC awards totaling $160.1M, and USAID invested $700 million in Kenya in FY2011. At least six NCI-designated cancer centers have activities in Kenya ranging from capacity building for cancer screening and treatment to studies of cancers associated with chronic infection, including HPV. Notably, Moi University has hosted the Academic Model Providing Access to Healthcare (AMPATH) partnership, along with Indiana University (IU), since 2001. The AMPATH-Moi-IU partnership has created the largest clinical research data enterprises in the developing world and includes 18 HIV clinics in western Kenya with 2,000 new patients enrolling per month as of 2012.
|
|
COVID CDEs (caDSR)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, CC, CIT, CSR, FIC, NCATS, NCCIH, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIMHD, NIMH, NIGMS, NIDDK, NIDCR, NIEHS, NINDS, NINR, NLM, OD/OER, OD/DPCPSI/ODSS, OD/DPCPSI/OBSSR, OD
|
Help develop COVID CDE metadata for submission to NIH governance and NIH/NLM CDE Repository
|
|
COVID-19 Scientific Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NCATS, CC, CIT, NHGRI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NLM, OD
|
The COVID-19 Scientific Interest Group was created in March 2020 in response to the COVID-19 pandemic. This interest group aims to promote collaboration and facilitate the exchange of information and resources among NIH intramural scientists and their HHS colleagues concerning research on COVID-19 and SARS-CoV-2.
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC
|
NIAID
|
To share updates on the wide range of COVID therapeutics efforts that are progressing across the agencies
|
|
Critical Crossroads Federal Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH, NINDS
|
The Critical Crossroads initiative, initiated by the Health Resources and Services Administration (HRSA) Emergency Medical Services for Children (EMSC) Program, seeks to collaborate across federal agencies to improve the identification of and care coordination for children experiencing mental health crises in rural emergency care settings. The project will identify resources and best practice tools that can be disseminated to states and rural communities. The goals of the project are to improve the coordination of care of children in emergency mental health crisis and post-crisis in rural regions and to provide training and policy resources to the Emergency Medical Services (EMS) and ED practitioners.
|
|
Cytokine Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR
|
The Cytokine Interest Group brings together the National Institutes of Health (NIH) and Food and Drug Administration (FDA) scientists from many different areas working with cytokines as mediators of immune processes. It provides a platform for establishing networks for the exchange of ideas and reagents. Its activities comprise multiple minisymposia throughout the year and an award for the best paper in cytokine research for postdoctoral fellows working at the NIH or FDA.
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
DailyMed provides high-quality information about marketed drugs, including FDA labels (package inserts). The website provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed as a public service, free of advertising.
|
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
National Institute on Aging (NIA) has an Inter-Agency Agreement (IAA) to assist grantees with accessing Centers for Medicare & Medicaid Services (CMS) data. It is anticipated that this initiative will create a more user-friendly and more cost-efficient means for grantees to access CMS data, especially the need to access Part D data. Specifically, this agreement gives CMS's Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. This includes activities for remote access data enclave.
|
|
Demand Reduction Interagency Working Groups
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation.
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, NHLBI
|
This committee oversees the Department of Defense (DoD) research in resuscitation and transfusion.
|